Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a brain zapping device help treat anorexia?

NCT ID NCT05814458

Symptom relief Sponsor: Medical University of Lublin Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tests whether a gentle brain stimulation technique called tDCS can improve mood, thinking, and eating habits in people with anorexia nervosa. Forty participants aged 10-30 will receive either real or sham stimulation twice daily for three weeks. The goal is to see if this safe, non-invasive approach can reduce depression and help with nutritional recovery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
transcranial direct current stimulation (tDCS) device
What this could lead to
If it works, this could point toward a non-invasive brain stimulation treatment to help reduce depression and improve eating behaviors in anorexia nervosa.
What could go wrong
This is a small, early-stage trial with only 40 participants. The treatment is short (3 weeks), and results may not last or apply to everyone. tDCS is generally safe but may cause mild scalp discomfort.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2022

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

10 to 30 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Signed written Informed Consent Form, * Patients aged 10-30 years old, * Meet the DSM-5 criteria for AN, * Body mass index (BMI) ≤ 17,5 kg/m2, * A willingness and motivation to follow the study protocol. Exclusion Criteria: * Not giving Informed, Written Consent * Diagnosis of neurological diseases, as epilepsy; * Contraindications to tDCS, ie. pacemakers, metal parts around the head; * Psychiatric comorbidities (except specific personality disorder) including mental retardation, organic brain dysfunction, or addiction (except nicotine and caffeine); * Pregnancy or pregnancy planning; * Changes in psychopharmacotherapy during hospitalization

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anorexia nervosa are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

anorexia nervosa Feeding and Eating Disorders

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anorexia nervosa

Contacts and locations

Locations

  • Ist Department of Psychiatry, Psychotherapy and Early Intervention

    Lublin, Lublin Voivodeship, 20-439, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.